Aurion Biotechnologies is a clinical-stage biotech company.
Aurion Biotechnologies has raised $120.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2022.
Aurion Biotechnologies's investors include Deerfield, Petrichor Healthcare Capital Management, Visionary Venture Fund, Alcon, Flying L Partners.
Aurion Biotechnologies is headquartered in Seattle, United States.
Aurion Biotechnologies is a clinical-stage biotech company.
Aurion Biotechnologies is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aurion Biotechnologies — Funding & Investors." VCBacked, April 12, 2022, https://www.vcbacked.co/company/aurion-biotechnologies. Accessed August 14, 2026.
VCBacked. (2022). Aurion Biotechnologies — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/aurion-biotechnologies
{{cite web |title=Aurion Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/aurion-biotechnologies |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated